CTRL (0.45 0.05% early apoptosis, 0.12 0.02% late apoptosis
CrossRef Proliferation and Apoptosis Adaptor Protein 15 (PEA15), a Potential Oncogenic Regulator of VHL and HIF1A Identified through Proteomic Analysis in Hepatocellular Carcinoma Yun Seong Jeong, Ji-Hyun Shin, Soo Mi Kim, Bo Hwa Sohn, Sun Young Yim, Ji Hoon Kim, Jae Jun Shim, Sung Hwan Lee, Yun Shin Chun, Sunyoung S
Trends in the global, regional, and National burden of oral conditions from 1990 to 2021: a systematic analysis for the global burden of disease study 2021
FDAs Pharmacy Compounding Advisory Committee (PCAC) is again reviewing certain peptide bulk drug substances
The most defensible reading is to treat each compounds own within-trial data as its evidence and to treat any cross-compound ranking as a hypothesis, not a result
Patients with severe chronic liver, heart or kidney disease will have to have an initial naturopathic consultation first with our Naturopathic Doctors to determine if they can receive IV therapy and that it does not interfere with any medication
